Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	12/14/2006 8:13:08 AM
	of 3044

Dr. Bob Tepper, President of R&D, to Leave Millennium Thursday December 14, 8:01 am ET CAMBRIDGE, Mass., Dec. 14 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM - News) today announced that R&D President Bob Tepper, M.D., is leaving the Company in the first quarter of 2007. Dr. Tepper was one of the founding executives of Millennium in 1994 and has steered the Company through its expansion from a drug discovery company to a fully-integrated biopharmaceutical company with nine novel molecules in the clinic and a market-leading product, VELCADE® (bortezomib) for Injection, for relapsed multiple myeloma and mantle cell lymphoma. "Bob was one of a small group of people who had a vision for forming a new company that could make a difference in the way medicine is discovered to change the lives of patients," said Millennium President and Chief Executive Officer Deborah Dunsire, M.D. "Today that vision is a reality and Millennium is indeed improving the lives of patients with multiple myeloma and mantle cell lymphoma, with a strong and diverse pipeline behind VELCADE. I would like to thank Bob for his vision and relentless commitment to scientific excellence." The Company is actively recruiting a successor.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next